BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/20/2021 9:33:19 AM | Browse: 709 | Download: 2436
 |
Received |
|
2021-05-11 10:00 |
|
Peer-Review Started |
|
2021-05-11 10:03 |
|
First Decision by Editorial Office Director |
|
2021-06-23 22:14 |
|
Return for Revision |
|
2021-06-24 02:13 |
|
Revised |
|
2021-07-07 21:44 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-07-14 03:33 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-07-14 09:47 |
|
Articles in Press |
|
2021-07-14 09:47 |
|
Edit the Manuscript by Language Editor |
|
2021-07-22 04:36 |
|
Typeset the Manuscript |
|
2021-08-16 07:13 |
|
Publish the Manuscript Online |
|
2021-08-20 09:33 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Hepatocellular injury and the mortality risk among patients with COVID-19: A retrospective cohort study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ali Madian, Ahmed Eliwa, Hytham Abdalla and Haitham A Azeem Aly |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ali Madian, MD, MSc, Lecturer, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, Al-Azhar University-Assiut, Al Walideyah Al Bahreyah, Assiut 71524, EG, Egypt. a.madian@azhar.edu.eg |
| Key Words |
COVID-19; Liver injury; Aspartate amino transferase; All-cause in-hospital mortality; Serum ferritin; SARS-CoV-2 |
| Core Tip |
Liver injury with an aspartate transferase (AST)-dominant pattern can be used to predict the severity of coronavirus disease 2019 (COVID-19). A one-fold increase in the serum AST level increases the odds of in-hospital mortality by eleven-fold compared with individuals with normal AST levels. Moreover, a two-fold increase in the serum AST levels increases the odds of mortality by thirteen-fold. Moreover, our study confirmed an elevated level of ferritin in patients with COVID-19. Increased ferritin levels are associated with fatal outcomes. Meticulous monitoring is highly recommended for patients with COVID-19 presenting AST-dominant hepatocellular injury, especially those older than 60 years, those with elevated ferritin levels or those with diabetes mellitus. |
| Publish Date |
2021-08-20 09:33 |
| Citation |
Madian A, Eliwa A, Abdalla H, Aly HAA. Hepatocellular injury and the mortality risk among patients with COVID-19: A retrospective cohort study. World J Hepatol 2021; 13(8): 939-948 |
| URL |
https://www.wjgnet.com/1948-5182/full/v13/i8/939.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v13.i8.939 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
